New Delhi: Drug major Sun Pharmaceutical Industries on Tuesday said its board has approved Rs 1,700 crore share buyback offer at a maximum price of Rs 425 per share.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Qmjyje
via IFTTT
Subscribe to:
Post Comments (Atom)
-
By Reuters via NYT World https://ift.tt/2vrReVu
-
The peril posed by the twin scourges of pestilence and material ruin brought on by the swift advance of the coronavirus deepened on Friday a...
-
By Christoph Koettl and Meg Felling via NYT World https://ift.tt/38m0Y0Q
No comments:
Post a Comment